Clincosm LogoSign in Get a demo

PENG and LFCN Block Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty

Sponsor
Minia University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05652075
Collaborator
(none)
66
Enrollment
1
Location
2
Arms
5.9
Anticipated Duration (Months)
11.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Regional anesthesia for postoperative analgesia in THA includes epidural anesthesia and peripheral nerve blocks. However epidural anesthesia has a great role in THA, it has become restricted as perioperative antithrombotic drugs are generally used for orthopedic patients.

the study aim to evaluate and compare efficacy and safety of pericapsular nerve group block (PENG) block and lateral femoral cutaneous nerve versus Lumbar plexus block on postoperative analgesia in hip surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: pericapsular nerve group and lateral femoral cutaneous nerve block
  • Procedure: lumbar plexus block
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Efficacy and Safety of Ultrasound Guided Combined Pericapsular Nerve Group Block and Lateral Femoral Cutaneous Nerve Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty: Randomized Clinical Study.
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: PENG and LFCN

Procedure: pericapsular nerve group and lateral femoral cutaneous nerve block
Will undergo pericapsular nerve group block (PENG) combined with lateral femoral cutaneous nerve under ultrasound guided block with 20 mL of 0.25% bupivacaine.
Experimental: lumbar plexus

Procedure: lumbar plexus block
Will undergo Lumbar plexus block (LPB) under ultrasound guided block with 20 mL of 0.25 % bupivacaine.

Outcome Measures

Primary Outcome Measures

  1. Visual analogue scale pain scores [24 hour]

    pain score from 0-10 which 0 mean no pain and 10 the worst pain

Secondary Outcome Measures

  1. first analgesic request [24 hour]

    time to demand nalbuphine

  2. total analgesic consumption [24 hour]

    total nalbuphine in mg consumed in the first day

  3. First time to ambulate [24 hours]

    first time to move

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

(ASA) physical status I to III scheduled for hip surgery aged (30-70) years

Exclusion Criteria:

  • Drug allergy,

  • Morbid obesity (BMI >40 kg/m2),

  • Coagulopathy,

  • Psychiatric disorder,

  • Opioid dependence,

  • Patient refusal to give informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Minia University Minya Minia Egypt 61511

Sponsors and Collaborators

  • Minia University

Investigators

  • Principal Investigator: hassan m. hetta, lecturer, minia university/ faculty of medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hassan Mokhtar Elshorbagy Hetta, lecturer of anesthesia and ICU, Minia University
ClinicalTrials.gov Identifier:
NCT05652075
Other Study ID Numbers:
  • 473:10/2022
First Posted:
Dec 15, 2022
Last Update Posted:
Jan 23, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hassan Mokhtar Elshorbagy Hetta, lecturer of anesthesia and ICU, Minia University
PENG
lumber plexus
hip surgery
Additional relevant MeSH terms:
Pain, Postoperative

Study Results

No Results Posted as of Jan 23, 2023